FilingReader Intelligence
Taiko Pharmaceutical boosts 2025 profit forecast 50% after subsidiary liquidation
August 20, 2025 at 12:06 PM UTC•By FilingReader AI
Taiko Pharmaceutical completed liquidation of its Shanghai subsidiary on August 11, generating a 142 million yen special gain from foreign currency translation adjustments.
The company revised its 2025 net income forecast upward by 50% to 450 million yen. Sales and operating profit forecasts remain unchanged.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
TSE:4574•Tokyo Stock Exchange
News Alerts
Get instant email alerts when Taiko Pharmaceutical publishes news
Free account required • Unsubscribe anytime